Evidence map›Paper›PMID 18599265›Full record

ArticleBrain, behavior, and immunity2008

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.

Mark R Hutchinson, Benjamen D Coats, Susannah S Lewis, Yingning Zhang, David B Sprunger, Niloofar Rezvani, Eric M Baker, Brian M Jekich, Julie L Wieseler, Andrew A Somogyi and 5 more

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 1 synthesis or guideline pooled it, 301 citations in OpenAlex.

  1. Pooled it
  2. Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  3. Trial
  4. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Trial
  5. Trial
  6. Trial
  7. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Frontiers in immunology · 2024
    Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Mark R HutchinsonDepartment of Psychology and The Center for Neuroscience, Campus Box 345, University of Colorado at Boulder, Boulder, CO 80309-0345, USA.
Benjamen D Coats
Susannah S Lewis
Yingning Zhang
David B Sprunger
Niloofar Rezvani
Eric M Baker
Brian M Jekich
Julie L Wieseler
Andrew A Somogyi
David Martin
Stephen Poole
Charles M Judd
Steven F Maier
Linda R Watkins
University of Colorado Boulder · USUniversity of Adelaide · AUAmgen (United States) · USNational Institute for Biological Standards and Control · GB

Funding

Pain facilitation via neuron-to-glia signalingR01DA017670 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WATKINS, LINDA · 2005 to 2009
$2.0M
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod ActionsR01DA023132 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$1.9M
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial ActivationR01DE017782 · NIDCR · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2006 to 2010
$1.9M
Immune and Gilia Regulation of Pain & Analgesic ActionsK05DA024044 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$616k
Immune/Glial Mediation of Exaggerated Pain StatesK02DA015642 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WATKINS, LINDA · 2003 to 2007
$600k
NIDA NIH HHS DA015642NIDA NIH HHS DA017670NIDA NIH HHS DA023132NIDA NIH HHS K02 DA015642NIDA NIH HHS K05 DA024044NIDA NIH HHS R01 DA017670NIDA NIH HHS R01 DA023132NIDCR NIH HHS DE017782NIDCR NIH HHS R01 DE017782
6 · The paper itself

Abstract

Spinal proinflammatory cytokines are powerful pain-enhancing signals that contribute to pain following peripheral nerve injury (neuropathic pain). Recently, one proinflammatory cytokine, interleukin-1, was also implicated in the loss of analgesia upon repeated morphine exposure (tolerance). In contrast to prior literature, we demonstrate that the action of several spinal proinflammatory cytokines oppose systemic and intrathecal opioid analgesia, causing reduced pain suppression. In vitro morphine exposure of lumbar dorsal spinal cord caused significant increases in proinflammatory cytokine and chemokine release. Opposition of analgesia by proinflammatory cytokines is rapid, occurring < or =5 min after intrathecal (perispinal) opioid administration. We document that opposition of analgesia by proinflammatory cytokines cannot be accounted for by an alteration in spinal morphine concentrations. The acute anti-analgesic effects of proinflammatory cytokines occur in a p38 mitogen-activated protein kinase and nitric oxide dependent fashion. Chronic intrathecal morphine or methadone significantly increased spinal glial activation (toll-like receptor 4 mRNA and protein) and the expression of multiple chemokines and cytokines, combined with development of analgesic tolerance and pain enhancement (hyperalgesia, allodynia). Statistical analysis demonstrated that a cluster of cytokines and chemokines was linked with pain-related behavioral changes. Moreover, blockade of spinal proinflammatory cytokines during a stringent morphine regimen previously associated with altered neuronal function also attenuated enhanced pain, supportive that proinflammatory cytokines are importantly involved in tolerance induced by such regimens. These data implicate multiple opioid-induced spinal proinflammatory cytokines in opposing both acute and chronic opioid analgesia, and provide a novel mechanism for the opposition of acute opioid analgesia.

Indexed as

AnalgesiaAnalgesics, OpioidAnimalsCatheters, IndwellingChemokine CX3CL1CytokinesHyperalgesiaInjections, SpinalInterleukin-1Interleukin 1 Receptor Antagonist ProteinMaleMethadoneMorphinePainPain MeasurementPain ThresholdAnalgesics, OpioidChemokine CX3CL1CytokinesInterleukin-1Interleukin 1 Receptor Antagonist ProteinMethadoneMorphineReceptors, Tumor Necrosis Factor, Type IRNA, Messenger

Identifiers

PMID18599265
PMCPMC2783238
OpenAlexW2034756951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.